We are aware of recent media reports that long-term use of bisphosphonates for osteoporosis (sold under the names of Fosamax [alendronate] and Actonel [risedronate]) may be associated with the occurrence […]

We are aware of recent media reports that long-term use of bisphosphonates for osteoporosis (sold under the names of Fosamax [alendronate] and Actonel [risedronate]) may be associated with the occurrence […]

IMPACT REPORT 2019 – 2020 PATIENT STORY: MEET MURRAY BOLTON For Murray, it all started with a broken wrist. The kind of accident that could happen to anyone, he reasoned. […]

Aliya Khan, Heather Frame,  Claudia Gagnon,  Rowena Ridout , Lianne Tile,  Wendy Ward, Sandra Kim Recently Duerksen and colleagues published on fracture risk assessment in celiac disease – a registry-based […]

No link between the use of bisphosphonates and the risk of cancer of the esophagus or stomach has also been noted in a recent large study from the UK. This […]

IMPACT REPORT 2020 – 2021 __________   PATIENT STORYJOYCE CRAWFORD Joyce’s father had osteoporosis and even though her grandmother wasn’t formally diagnosed, she had signs of the disease including her […]

MEET THE CMC FACULTY Dr. Cathy Craven University of Toronto  Toronto, ON Cathy Craven is the Toronto Rehabilitation Institute/ University of Toronto Chair in Spinal Cord Injury (SCI) Rehabilitation, Professor […]

Prepared and reviewed by members of the Scientific Advisory Council of Osteoporosis Canada • Dr. Rick Adachi, Rheumatologist, McMaster University • Dr. Robert Josse, Endocrinologist, University of Toronto • Dr. […]

A UNIQUE WAY TO CREATE AWARENESS ABOUT BONE HEALTH Attendees of Toronto Fashion Week saw something unusual on the catwalk this year: a line of innovative fashions incorporating bubble wrap! […]